Evidence for synthetic lethality between bevacizumab and chemotherapy in advanced, p53 null endometrial cancers
| Autor: | Mallen, A.R., Filiaci, V.L., Levine, D.A., Thiel, K., Aghajanian, C.A., Meng, X., Devor, E., Moore, K.N., Powell, M.A., Secord, A.A., Tewari, K.S., Bender, D.P., Stuckey, A.R., Fowler, J.M., Dewdney, S.B., Leslie, K.K. |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2018 149 Supplement 1:29-30 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect